FOXN3 Regulates Hepatic Glucose Utilization

Slides:



Advertisements
Similar presentations
Cardiac-Specific Overexpression of HIF-1α Prevents Deterioration of Glycolytic Pathway and Cardiac Remodeling in Streptozotocin-Induced Diabetic Mice 
Advertisements

Volume 21, Issue 2, Pages (October 2017)
FOXN3 Regulates Hepatic Glucose Utilization
Regulation of expression of murine transferrin receptor 2
MTORC1 Balances Cellular Amino Acid Supply with Demand for Protein Synthesis through Post-transcriptional Control of ATF4  Yeonwoo Park, Andrea Reyna-Neyra,
Volume 134, Issue 2, Pages (July 2008)
Volume 21, Issue 2, Pages (October 2017)
Volume 11, Issue 2, Pages (August 2012)
Volume 13, Issue 9, Pages (December 2015)
Volume 136, Issue 2, Pages (February 2009)
Volume 19, Issue 3, Pages (April 2017)
Neuropeptide Y Regulates Sleep by Modulating Noradrenergic Signaling
Volume 53, Issue 3, Pages (September 2010)
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 23, Issue 5, Pages (May 2018)
Volume 21, Issue 11, Pages (December 2017)
Sherilyn Grill, Valerie M. Tesmer, Jayakrishnan Nandakumar 
Volume 57, Issue 2, Pages (January 2015)
Volume 13, Issue 8, Pages (November 2015)
A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose
Functional Modulation of Gene Expression by Ultraconserved Long Non-coding RNA TUC338 during Growth of Human Hepatocellular Carcinoma  Hui-Ju Wen, Michael.
Volume 18, Issue 2, Pages (April 2005)
Volume 3, Issue 2, Pages (February 2013)
Minchul Kim, Taekhoon Kim, Randy L. Johnson, Dae-Sik Lim  Cell Reports 
Volume 93, Issue 5, Pages (May 1998)
BZR1 Positively Regulates Freezing Tolerance via CBF-Dependent and CBF- Independent Pathways in Arabidopsis  Hui Li, Keyi Ye, Yiting Shi, Jinkui Cheng,
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Volume 16, Issue 3, Pages (March 2015)
Interplay between Nonsense-Mediated mRNA Decay and DNA Damage Response Pathways Reveals that Stn1 and Ten1 Are the Key CST Telomere-Cap Components  Eva-Maria.
Volume 136, Issue 6, Pages (March 2009)
Volume 17, Issue 8, Pages (November 2016)
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
Volume 8, Issue 2, Pages (August 2008)
Volume 9, Issue 1, Pages (January 2016)
A LIN28B Tumor-Specific Transcript in Cancer
Volume 9, Issue 6, Pages (December 2014)
Melissa L. Ehlers, Barbara Celona, Brian L. Black  Cell Reports 
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Codependent Activators Direct Myoblast-Specific MyoD Transcription
Volume 21, Issue 9, Pages (November 2017)
Volume 13, Issue 12, Pages (December 2015)
Volume 63, Issue 3, Pages (August 2016)
Functional Genomic Analysis of Human Mitochondrial RNA Processing
PAS Kinase Drives Lipogenesis through SREBP-1 Maturation
Volume 26, Issue 3, Pages (May 2007)
Hung-Chun Chang, Leonard Guarente  Cell 
Volume 15, Issue 5, Pages (May 2016)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Maria S. Robles, Sean J. Humphrey, Matthias Mann  Cell Metabolism 
Volume 17, Issue 3, Pages (October 2016)
Volume 20, Issue 13, Pages (September 2017)
Volume 26, Issue 11, Pages e5 (March 2019)
Volume 26, Issue 11, Pages e4 (March 2019)
Shipra Das, Olga Anczuków, Martin Akerman, Adrian R. Krainer 
Arisa Hirano, Daniel Braas, Ying-Hui Fu, Louis J. Ptáček  Cell Reports 
Volume 41, Issue 2, Pages (January 2011)
Hepatocyte Growth Factor Regulates the miR-206-HDAC4 Cascade to Control Neurogenic Muscle Atrophy following Surgical Denervation in Mice  Wooshik Choi,
Nucleoporin Nup98 Associates with Trx/MLL and NSL Histone-Modifying Complexes and Regulates Hox Gene Expression  Pau Pascual-Garcia, Jieun Jeong, Maya.
Boyan Bonev, Peter Stanley, Nancy Papalopulu  Cell Reports 
Volume 49, Issue 2, Pages (January 2013)
Ctip2 directly regulates Notch1 expression in differentiated cells.
A Long Non-coding RNA, lncLGR, Regulates Hepatic Glucokinase Expression and Glycogen Storage during Fasting  Xiangbo Ruan, Ping Li, Andrew Cangelosi,
Volume 26, Issue 8, Pages e7 (February 2019)
Volume 2, Issue 3, Pages (September 2012)
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
Volume 23, Issue 10, Pages (June 2018)
Volume 26, Issue 11, Pages e6 (March 2019)
MRT, Functioning with NURF Complex, Regulates Lipid Droplet Size
Presentation transcript:

FOXN3 Regulates Hepatic Glucose Utilization Santhosh Karanth, Erin K. Zinkhan, Jonathon T. Hill, H. Joseph Yost, Amnon Schlegel  Cell Reports  Volume 15, Issue 12, Pages 2745-2755 (June 2016) DOI: 10.1016/j.celrep.2016.05.056 Copyright © 2016 The Author(s) Terms and Conditions

Cell Reports 2016 15, 2745-2755DOI: (10.1016/j.celrep.2016.05.056) Copyright © 2016 The Author(s) Terms and Conditions

Figure 1 The rs8004664 Risk Allele Increases FOXN3 Gene Expression (A) The 514.28-kb FOXN3 locus is on the reverse strand of human chromosome 14. The -003 transcripts variant encodes the full-length protein. Four other major, protein-coding transcript variants are annotated in GENCODE 24. Note the location of rs8004664, within the first, large intron. Transcript variant -T001 encodes a 468-aminoacyl residue (aa) protein; -T003 encodes a 490-aa protein; -T004 encodes a 468-aa protein; -T201 encodes a 490-aa protein; and -T202 encodes a 468-aa protein. (B) Allele frequencies in the 1000 Genomes dataset. “A” is the hyperglycemia risk allele. The overall minor (risk) allele frequency is 30%. (C) The distance in base pairs of the nearest SNPs in linkage disequilibrium to rs8004664 is shown in the table (left). Linkage disequilibrium (R2 values) and recombination rate (cM/Mb) plots for the 10-kb flanking the rs8004664 are shown for the entire 1000 Genomes dataset (plotted with SNAP). Note the chromosomal position of rs8004664 is different from that shown in (A) because different builds of the human genome were queried. (D) Steady-state transcript abundance of FOXN3-T003 and -T004 in cryopreserved human hepatocytes from donors with the indicated rs8004664 genotypes, G|G (n = 2), A|G (n = 8), and A|A (n = 6). Horizontal lines indicate the median value. Transcript variant -T003 is the most abundant, followed by -T004. Mean ± SEM values are shown. Ct = 26.9 ± 0.3 for -T003 and 31.7 ± 0.4 cycles for -T004. ∗p = 0.03; two-tailed Student’s t test. (E and F) Sufficient protein was retrieved from 12 of the 16 donor liver samples analyzed in (D) for immunoblot analysis. FOXN3 protein showed a similar trend as FOXN3 transcript, with increasing abundance proportional to the number of rs8004664 risk alleles present. Horizontal lines indicate the median value. ∗p = 0.06; two-tailed Student’s t test. TUBB, β-tubulin. See also Figure S1 and Table S1. Cell Reports 2016 15, 2745-2755DOI: (10.1016/j.celrep.2016.05.056) Copyright © 2016 The Author(s) Terms and Conditions

Figure 2 FOXN3 Is Nutritionally Regulated (A) HepG2 cells were grown in complete medium (0 hr) and then subjected to nutrient deprivation for the indicated times (all in hours). Where indicated, samples were returned to complete medium for the indicated time (“+”), and RT-PCR was performed to measure FOXN3-T003 and FOXN3-T004 transcript abundance. Mean ± SEM values are shown. ∗p < 0.001; one-way ANOVA. (B and C) Immunoblot analysis and densitometric analysis were performed for human FOXN3 and TUBB at the times indicated in (A). Mean ± SEM values are shown. p = 0.06 in one-way ANOVA. n = 3. (D and E) Foxn3 protein abundance was quantified with immunoblot analysis of liver homogenates from fed and fasted rat livers. Mean ± SEM values are shown. ∗p = 0.0007; two-tailed Student’s t test. (F) foxn3 transcript abundance was measured in fed and fasted adult zebrafish livers. Mean ± SEM values are shown. ∗p < 0.004; two-tailed Student’s t test. n = 6. Cell Reports 2016 15, 2745-2755DOI: (10.1016/j.celrep.2016.05.056) Copyright © 2016 The Author(s) Terms and Conditions

Figure 3 FOXN3 Drives Increased Hepatic Glucose Production (A) Human FOXN3 and zebrafish Foxn3 orthologs are shown with the central DNA-binding Forkhead box (nearly invariant aminoacyl residues 112–204) and length marked (to the right). The percent identity of the zebrafish amino-terminus, Forkhead box, and C terminus relative to human FOXN3 is shown. The conserved Sin3-binding signature (EAA within the C terminus) is marked. Putative phosphorylation sites found in five or more published phospho-proteomic surveys are shown as well: the significance of these residues’ phosphorylation has not been established in any organism. (B) A non-transgenic (wild-type [WT]) 7 days post-fertilization (dpf) larva and two transgenic larvae were photographed in light- and green fluorescent channels in the left-lateral view. The Tg(fabp10a:foxn3,EGFP)z106 transgenic line overexpresses zebrafish foxn3 and EGFP, and the Tg(fabp10a:FOXN3,EGFP)z107 transgenic line overexpresses human FOXN3 and EGFP (transcript variant -T003). The encoded EGFP protein is translated as a free (not as a fusion) protein (Provost et al., 2007). The scale bar represents 500 μm. (C and D) pck1 promoter activity (bioluminescence derived from assay of luciferase) in lysates prepared from 5 and 6 days post-fertilization (dpf), never-fed Tg(pck1:Luc2,cryaa:mCherry)s952, Tg(fabp10a:foxn3,EGFP)z106; Tg(pck1:Luc2,cryaa:mCherry)s952 and Tg(fabp10a:FOXN3,EGFP)z107; and Tg(pck1:Luc2,cryaa:mCherry)s952 larvae. p < 0.02; two-tailed Student’s t test. n = 5–7. (E and F) Whole-body glucose levels in 6 dpf WT, Tg(fabp10a: foxn3,EGFP)z106, and Tg(fabp10a:FOXN3,EGFP)z107 larval extracts. ∗p < 0.02; two-tailed Student’s t test. n = 4–5 pooled samples of ten larvae each. All values are mean ± SEM. (G and H) Fasting blood glucose levels in WT, Tg(fabp10a: foxn3,EGFP)z106, and Tg(fabp10a:FOXN3,EGFP)z107 transgenic adult animals of both sexes after an overnight fast.∗p = 0.01; two-tailed t Student’s t test. n = 9–13. Cell Reports 2016 15, 2745-2755DOI: (10.1016/j.celrep.2016.05.056) Copyright © 2016 The Author(s) Terms and Conditions

Figure 4 FOXN3 Suppresses MYC Expression (A) Volcano plot of differentially expressed transcripts from the RNA pools (n = 3) extracted from the livers of never-fed WT and Tg(fabp10a: foxn3,EGFP)z106 larvae. Note the adjusted p values are plotted on a log base 10 scale, with higher values indicating increased significance. (B) qPCR validation of the indicated mRNA steady-state levels in the livers of WT and Tg(fabp10a: foxn3,EGFP)z106 adult livers. Mean ± SEM values are shown. ∗p < 0.05; two-tailed Student’s t test (n = 5). slc2a2, solute carrier family 2 (facilitated glucose transporter), member 2. (C) MYC transcript abundance in cryopreserved human hepatocytes. Horizontal lines indicate the median value. ∗p < 0.05; two-tailed Student’s t test. (D and E) The membrane shown in Figure 1E was immunoblotted with anti-MYC IgG, and the density of the MYC band was normalized to the TUBB band densities; this is the same blot as in Figure 1E. Horizontal lines indicate the median value. ∗p = 0.019 by Mann-Whitney rank sum test after excluding an outlier (determined using the Grub’s test) from the A|A genotype values. (F) Structure of the zebrafish mycb gene. A Forkhead binding site and a MYC binding site (E box) are located distal to the 3′ UTR. The target PCR product for the ChIP assay is underlined. (G) qPCR analysis following ChIP with the indicated antibodies was performed in WT and Tg(fabp10a:FOXN3,EGFP)z107 livers. Fold enrichment was calculated relative to the mouse IgG levels. Mean ± SEM values are shown. n = 3. See also Table S1 and Figure S2. Cell Reports 2016 15, 2745-2755DOI: (10.1016/j.celrep.2016.05.056) Copyright © 2016 The Author(s) Terms and Conditions

Figure 5 FOXN3 Overexpression Suppresses Glycolytic Gene Expression qPCR analysis of the indicated transcripts encoding glycolytic enzymes in WT and Tg(fabp10a:foxn3,EGFP)z106 livers. Horizontal lines indicate the mean value. Two-tailed Student’s t test results are shown. See also Figure S3. Cell Reports 2016 15, 2745-2755DOI: (10.1016/j.celrep.2016.05.056) Copyright © 2016 The Author(s) Terms and Conditions

Figure 6 Model for How FOXN3 Suppresses MYC Transcription and Blunts Hepatic Glucose Utilization During the fasted state (left), normally reduced FOXN3 expression allows for increased MYC expression. MYC regulates the expression of numerous genes encoding enzymes of glycolytic and tricarboxylic acid (TCA) cycle flux in hepatocytes, thereby promoting net hepatic glucose utilization during the fasted state. Conversely, during the fed state or when overexpressed in hepatocytes either transgenically or through the rs8004664 risk allele’s direction (right), increased FOXN3 represses MYC gene expression, leading to reduced glycolytic gene expression and flux through glycolysis and the TCA cycle decrease (noted by altered weight of arrows and circle). In parallel, gluconeogenesis is induced by FOXN3, as noted with red arrows for the hypothesized route of carbon atoms. The net effect of increased FOXN3 expression and reduced MYC expression is increased hepatic glucose production, leading to pathologically increased blood glucose concentrations. Cell Reports 2016 15, 2745-2755DOI: (10.1016/j.celrep.2016.05.056) Copyright © 2016 The Author(s) Terms and Conditions